Patents by Inventor Hashem Alsaab

Hashem Alsaab has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250049945
    Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.
    Type: Application
    Filed: July 22, 2024
    Publication date: February 13, 2025
    Applicant: Wayne State University
    Inventors: Samaresh Sau, Arun K. Iyer, Hashem Alsaab
  • Patent number: 12083187
    Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.
    Type: Grant
    Filed: December 28, 2018
    Date of Patent: September 10, 2024
    Assignee: WAYNE STATE UNIVERSITY
    Inventors: Samaresh Sau, Arun K. Iyer, Hashem Alsaab
  • Publication number: 20200338211
    Abstract: Advancements in solid tumor (e.g., renal cell carcinoma) treatments and imaging are described. The advancements are based on nanoformulations that: (i) overcome deliverability issues associated with anti-cancer compounds; (ii) have increased targeted delivery to tumors, and hypoxic cores of tumors due to the presence of targeting ligands; (iii) have increased delivery to the hypoxic cores of tumors due to engineered shapes; (iv) provide synergistic treatment combinations; and/or (v) overcome cancer cell resistance to therapeutic treatments.
    Type: Application
    Filed: December 28, 2018
    Publication date: October 29, 2020
    Applicant: Wayne State University
    Inventors: Samaresh Sau, Arun K. Iyer, Hashem Alsaab